tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AU:ALA Stock Latest News

Arovella Wins FDA IND Clearance for Lead Cell Therapy ALA-101
Company AnnouncementsArovella Wins FDA IND Clearance for Lead Cell Therapy ALA-101
4d ago
Arovella Files IND for Lead CAR-iNKT Therapy as Cash Reserves Back 2026 Clinical Push
PremiumCompany Announcements
Arovella Files IND for Lead CAR-iNKT Therapy as Cash Reserves Back 2026 Clinical Push
10d ago
Arovella Therapeutics Names New Company Secretary and CFO to Support Growth
PremiumCompany Announcements
Arovella Therapeutics Names New Company Secretary and CFO to Support Growth
11d ago
Arovella to Release 936,303 Escrowed Shares Issued for Investor Relations Services
PremiumCompany Announcements
Arovella to Release 936,303 Escrowed Shares Issued for Investor Relations Services
18d ago
Arovella Seeks FDA Green Light for First-in-Human Trial of Lead CAR-iNKT Therapy
PremiumCompany Announcements
Arovella Seeks FDA Green Light for First-in-Human Trial of Lead CAR-iNKT Therapy
1M ago
Arovella Therapeutics Issues New Shares to Bolster Cancer Therapy Development
PremiumCompany AnnouncementsArovella Therapeutics Issues New Shares to Bolster Cancer Therapy Development
2M ago
Arovella Therapeutics Expands Market Presence with New Securities Quotation
Premium
Company Announcements
Arovella Therapeutics Expands Market Presence with New Securities Quotation
2M ago
Arovella Therapeutics Director Adjusts Shareholding
Premium
Company Announcements
Arovella Therapeutics Director Adjusts Shareholding
2M ago
Arovella Therapeutics Expands Share Issuance to Bolster Cancer Therapy Development
PremiumCompany Announcements
Arovella Therapeutics Expands Share Issuance to Bolster Cancer Therapy Development
2M ago
Arovella Therapeutics Announces Cessation of Securities
PremiumCompany Announcements
Arovella Therapeutics Announces Cessation of Securities
2M ago
Arovella Therapeutics Expands Market Presence with New Securities Quotation
PremiumCompany Announcements
Arovella Therapeutics Expands Market Presence with New Securities Quotation
2M ago
Arovella Therapeutics Announces Investor Presentation Update
PremiumCompany Announcements
Arovella Therapeutics Announces Investor Presentation Update
3M ago
Arovella Therapeutics Announces Director’s Change in Securities Holdings
PremiumCompany AnnouncementsArovella Therapeutics Announces Director’s Change in Securities Holdings
3M ago
Arovella Therapeutics Issues New Shares to Bolster Cancer Therapy Development
Premium
Company Announcements
Arovella Therapeutics Issues New Shares to Bolster Cancer Therapy Development
3M ago
Arovella Therapeutics Announces Cessation of Securities
Premium
Company Announcements
Arovella Therapeutics Announces Cessation of Securities
3M ago
Arovella Therapeutics Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Arovella Therapeutics Announces Quotation of New Securities on ASX
3M ago
Arovella Therapeutics Appoints New Director with No Initial Securities Interest
PremiumCompany Announcements
Arovella Therapeutics Appoints New Director with No Initial Securities Interest
3M ago
Arovella Therapeutics Advances CAR-iNKT Cell Platform with Baylor College Collaboration
PremiumCompany Announcements
Arovella Therapeutics Advances CAR-iNKT Cell Platform with Baylor College Collaboration
3M ago
Arovella Therapeutics Secures Shareholder Support at AGM
PremiumCompany Announcements
Arovella Therapeutics Secures Shareholder Support at AGM
3M ago
Arovella Therapeutics Highlights Progress at Annual General Meeting
PremiumCompany AnnouncementsArovella Therapeutics Highlights Progress at Annual General Meeting
3M ago
Arovella Therapeutics Advances Clinical Trials and Expands Cancer Research
Premium
Company Announcements
Arovella Therapeutics Advances Clinical Trials and Expands Cancer Research
3M ago
Arovella Therapeutics Advances ALA-101 Clinical Program with SAPRO Partnership
Premium
Company Announcements
Arovella Therapeutics Advances ALA-101 Clinical Program with SAPRO Partnership
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >